Stomach Cancer Trial, Recruiting NCT06597227 Sponsor: Guihua Wang Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT06597227
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Note: The eligibility criteria provided for this trial appear to list the same inclusion criteria twice, with no separate exclusion criteria included in the source document. The information below reflects exactly what was provided. Confirm any exclusion criteria directly with the trial site.


Who might be able to join this trial:

  • People aged 18 to 75 years old at the time of signing consent, both male and female
  • People with a confirmed diagnosis of upper stomach cancer (adenocarcinoma) that is locally advanced, based on tissue or cell testing, and assessed by the trial doctors as removable or potentially removable by surgery
  • People who have not yet received any treatment for their current stomach cancer, including chemotherapy, radiation, or immunotherapy
  • People who are reasonably active and able to care for themselves, as rated on a standard health performance scale (ECOG score of 0–1)
  • People with an expected survival of at least 6 months
  • People who have had imaging scans (CT or PET-CT) of the chest, abdomen, and pelvis confirming the cancer has not spread to distant parts of the body
  • People whose blood test results meet minimum levels for red blood cells, white blood cells, and platelets, without recent blood transfusions or blood-stimulating medications
  • People whose liver and kidney function blood tests are within acceptable ranges
  • People whose blood clotting test results are within acceptable ranges
  • People whose heart pumping function, measured by ultrasound, is at least 50%
  • People who are able to voluntarily agree to participate and sign a consent form
  • People who are able to use appropriate contraception during the study and for 120 days after it ends, test negative for pregnancy within 7 days before joining, and are not currently breastfeeding (applies to people who could become pregnant)

Who may not be able to join:

  • The source document did not provide separate exclusion criteria — please confirm with the trial site directly

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86-027-83665215

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Guihua Wang
Registry
ClinicalTrials.gov
Start date
1 March 2024
Est. completion
30 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

3-year Disease-free survival (DFS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov